Aarti Drugs Results Earnings Call for Q4FY24
Conference Call with Aarti Drugs Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.06-05-2024
06-05-2024
AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of share certificate.04-05-2024
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Financial Results.04-05-2024
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the Quater and Year ended March 31, 2024.04-05-2024
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release on financial results for the quarter and year ended March 31, 202403-05-2024
AARTI DRUGS LTD. - 524348 - Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2024
Financial Results for the quarter and year ended March 31, 202403-05-2024
AARTI DRUGS LTD. - 524348 - Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2024 And Outcome Of The Meeting Of Board Of Directors Held On May 3, 2024.
Audited Standalone and Consolidated Financial Results for the Quarter and Year ended March 31, 2024 and Outcome of the Meeting of Board of Directors held on May 3, 2024.03-05-2024
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is with reference to our letter bearing Ref No. ADL/SE/2024-25/09 dated April 29, 2024, we would like to inform to you that the scheduled Quarterly Earning Conference Call for the Investors and Analysts on Monday, May 6, 2024 at 12:00 noon IST has been re-scheduled and will now take place at 11:00 A.M IST on the same day i.e. May 6, 2024.30-04-2024
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform you that Quarterly Earning Conference Call for the Investors and Analysts has been scheduled on Monday, May 6, 2024 at 12:00 noon IST to discuss the Company's financial performance for the Quarter ended March 31, 2024.29-04-2024
AARTI DRUGS LTD. - 524348 - Board Meeting Intimation for Financial Results For The Quarter And Year Ended March 31, 2024
AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/05/2024 ,inter alia, to consider and approve Audited Financial Results for the Quarter and year ended March 31, 2024.26-04-2024